MYND Life Sciences MYNDF Stock
MYND Life Sciences Price Chart
MYND Life Sciences MYNDF Financial and Trading Overview
| MYND Life Sciences stock price | 0.0100 USD |
| Previous Close | 0.05 USD |
| Open | 0.05 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.01 - 0.14 USD |
| Volume | 735 USD |
| Avg. Volume | 309 USD |
| Market Cap | 2.33M USD |
| Beta (5Y Monthly) | 0.668316 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYNDF Valuation Measures
| Enterprise Value | 5.06M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.99 |
Trading Information
MYND Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.668316 |
| 52-Week Change | -31.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.14 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.04 USD |
| 200-Day Moving Average | 0.04 USD |
MYNDF Share Statistics
| Avg. Volume (3 month) | 309 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 46.82M |
| Float | 32.55M |
| Short Ratio | N/A |
| % Held by Insiders | 31.12% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -130.92% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2541872 USD |
| Net Income Avi to Common (ttm) | -3094865 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 2.73M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.03 |
| Book Value Per Share (mrq) | -0.093 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -70254 USD |
| Levered Free Cash Flow (ttm) | 566.85K USD |
Profile of MYND Life Sciences
| Country | United States |
| State | BC |
| City | Kelowna |
| Address | 733 Finns Road |
| ZIP | V1X 5B7 |
| Phone | N/A |
| Website | https://www.myndsciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.
Q&A For MYND Life Sciences Stock
What is a current MYNDF stock price?
MYND Life Sciences MYNDF stock price today per share is 0.0100 USD.
How to purchase MYND Life Sciences stock?
You can buy MYNDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MYND Life Sciences?
The stock symbol or ticker of MYND Life Sciences is MYNDF.
Which industry does the MYND Life Sciences company belong to?
The MYND Life Sciences industry is Biotechnology.
How many shares does MYND Life Sciences have in circulation?
The max supply of MYND Life Sciences shares is 241.22M.
What is MYND Life Sciences Price to Earnings Ratio (PE Ratio)?
MYND Life Sciences PE Ratio is now.
What was MYND Life Sciences earnings per share over the trailing 12 months (TTM)?
MYND Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the MYND Life Sciences company belong to?
The MYND Life Sciences sector is Healthcare.